We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Mycoplasma-Like Organism Associated with Common Vaginal Infection

By LabMedica International staff writers
Posted on 18 Apr 2013
A common sexually transmitted infection-causing parasite appears to cultivate bacteria beneficial to it, causing severe symptoms in patients. More...


A change in vaginal bacteria causes bacterial vaginosis (BV), and women with this condition are at increased risk of acquiring a Trichomonas vaginalis infection and among such women, there are unique bacterial communities, which would make them more susceptible to infection with the parasite.

Scientists at Louisiana State University (New Orleans, LA, USA) analyzed vaginal samples from 30 T. vaginalis positive (TV+) women and matched them by Nugent score to 30 women who were negative for T. vaginalis (TV-). Equal numbers of normal, intermediate and BV cases were included. The data was collected from 2003 to 2004.

Vaginal microbiota was assessed using 454 pyrosequencing analysis of polymerase chain reaction (PCR)-amplified 16S ribosomal ribonucleic acid (rRNA) gene sequences. The 16S rRNA gene sequence of an unknown organism was obtained by universal bacterial PCR amplification, cloning, and sequencing. The PCR amplicons were cloned using a TOPO TA cloning kit (Life Technologies; Carlsbad, CA, USA).

The investigators discovered that there were two unique bacterial communities that were very strongly associated with trichomonas infection. One of the mycoplasma associated with the unique bacterial community is Mycoplasma hominis, a well-known bacterial pathogen and the other is previously unknown Mycoplasma, called Mnola, and was present in 63% of TV+ infected women. Another organism most strongly associated with TV+ is Parvimonas, a well-known oral pathogen associated with dental root canal infections.


The data indicate that women with trichomonas and this unique bacterial community suffer from worse disease than the other trichomonas-infected women. They have greater amounts of discharge and redness of the vaginal wall. David H. Martin, MD, the senior author of the study said, "We think that this group might also be at especially high risk for infection with human immunodeficiency virus (HIV). So instead of these unique communities predisposing a woman to infection as originally thought, we now believe that trichomonas takes on the role of a farmer in the vaginal environment by cultivating bacterial communities that are in some way beneficial to itself." The study was published on March 15, 2013, in the Journal of Infectious Diseases.

Related Links:

Louisiana State University
Life Technologies




Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Serological Pipet Controller
PIPETBOY GENIUS
New
Hemoglobin Stool Test
CerTest FOB 50 + 200 One Step Combo Card Test
New
Varicella Zoster Test
ZEUS ELISA Varicella Zoster IgG Test System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The precision oncology test identifies patients most at risk of undergoing severe toxicity from treatment with 5FU/capecitabine (Photo courtesy of 123RF)

Precision Oncology Test Predicts Patient Toxicity Before Beginning Chemotherapy

5-fluorouracil (5FU) and capecitabine have been cornerstone chemotherapeutic agents for over four decades, effectively treating a variety of cancers. However, 5FU/capecitabine can cause varying degrees... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: Custom hardware and software for the real-time detection of immune cell biophysical signatures in NICU (Photo courtesy of Pediatric Research, DOI:10.1038/s41390-025-03952-y)

First-Of-Its-Kind Device Profiles Newborns' Immune Function Using Single Blood Drop

Premature infants are highly susceptible to severe and life-threatening conditions, such as sepsis and necrotizing enterocolitis (NEC). Newborn sepsis, which is a bloodstream infection occurring in the... Read more

Pathology

view channel
Image: Mimix Reference Standards are cell-line derived to maintain genomic complexity and mimic patient material across molecular diagnostics workflows (Photo courtesy of Revvity)

New Cancer Testing Standards to Improve Diagnostic Accuracy for Oncology Labs

Accurate diagnosis, including the identification of genomic markers, is essential for determining the most effective cancer treatments for patients. To ensure this, laboratories require reliable reference... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.